Medicare Enrolled

Dr. Gabriel Young, M.D.

Internal Medicine · Cupertino, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10011 N FOOTHILL BLVD, Cupertino, CA 95014
4083660600
In practice since 2006 (19 years)
NPI: 1811084114 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Young from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Young? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Young

Dr. Gabriel Young is an internal medicine specialist in Cupertino, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Young performed 577 Medicare services across 344 unique beneficiaries.

Between the years covered by Open Payments, Dr. Young received a total of $10,366 from 27 pharmaceutical and/or device companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Young is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 50% volume in CA $10,366 industry payments

Medicare Practice Summary

Medicare Utilization ↗
577
Medicare services
Top 50% in CA for internal medicine
344
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~30 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
289 $141 $483
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
71 $13 $100
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
67 $117 $410
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
32 $37 $100
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
30 $72 $162
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
26 $8 $42
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
19 $156 $337
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
17 $3 $79
New patient office visit, complex (60-74 min) 14 $144 $629
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $65 $276
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,366
Total received (2018-2024)
Avg $1,481/year across 7 years
Top 10% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
275
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,366 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,521
2023
$1,978
2022
$1,210
2021
$1,314
2020
$1,117
2019
$1,734
2018
$1,492

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
IBSA Pharma Inc.
$376
Amgen Inc.
$292
Teva Pharmaceuticals USA, Inc.
$254
Lilly USA, LLC
$154
GlaxoSmithKline, LLC.
$150
Gilead Sciences, Inc.
$145
SK Life Science, Inc.
$79
PFIZER INC.
$43
ABBVIE INC.
$28
Top 3 companies account for 60.6% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$2,486
Gilead Sciences, Inc.
$1,891
Teva Pharmaceuticals USA, Inc.
$880
IBSA Pharma Inc.
$772
Amgen Inc.
$561
Amarin Pharma Inc.
$516
Novo Nordisk Inc
$425
Boehringer Ingelheim Pharmaceuticals, Inc.
$384
PFIZER INC.
$372
AstraZeneca Pharmaceuticals LP
$347
GlaxoSmithKline, LLC.
$275
SANOFI-AVENTIS U.S. LLC
$232
Lilly USA, LLC
$187
Radius Health, Inc.
$144
Medtronic, Inc.
$143
Genentech USA, Inc.
$129
SI-BONE, INC.
$129
GENZYME CORPORATION
$125
SK Life Science, Inc.
$79
Novartis Pharmaceuticals Corporation
$72
Scilex Pharmaceuticals Inc.
$61
AbbVie Inc.
$49
Allergan Inc.
$32
ABBVIE INC.
$28
Allergan, Inc.
$17
Merck Sharp & Dohme Corporation
$16
Emergent BioSolutions Inc.
$15
Top 3 companies account for 50.7% of all-time payments
Associated products mentioned in payments ›
AREXVY · AUSTEDO · Austedo XR · BASAGLAR · DUPIXENT · ELIQUIS · ENTRESTO · Evera · FARXIGA · INVOKANA · JANUVIA · JARDIANCE · KYPHON EXPRESS II KYPHOPAK TRAY · LICART · Licart · MOUNJARO · NAMZARIC · Narcan · OFEV · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · Repatha · SHINGRIX · SOLIQUA 100/33 · SYMBICORT · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tresiba · Tymlos · UZEDY · VRAYLAR · Vascepa · Vemlidy · Victoza · XARELTO · XCOPRI · Xofluza · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in CA.

Looking for an internal medicine specialist in Cupertino?
Compare internal medicine physicians in the Cupertino area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,436
Per 100K population
128.0
County median income
$159,674
Nearest hospital
EL CAMINO HEALTH
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Young is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Young experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Young performed 289 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Young receive payments from pharmaceutical companies?
Yes. Dr. Young received a total of $10,366 from 27 companies across 275 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Young's costs compare to other internal medicine physicians in Cupertino?
Dr. Young's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Young) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →